Stanford University’s Faculty Senate today approved the creation of what officials believe is the first PhD program devoted solely to stem cell science in the nation and, perhaps, the world. The new doctoral program in stem cell biology and regenerative medicine is also the first interdisciplinary doctoral program created by the School of Medicine in recent years.
School officials say the fact that the university is taking the rare step of creating a new doctoral program acknowledges the growing importance of stem cell research in the realm of biomedical science. The senate’s initial approval of the program extends for five years.
“Stem cell biology is a distinct discipline that requires unique skills and includes a scope of knowledge and a skill set that is not covered by other disciplines,” said Renee Reijo Pera, PhD, professor of obstetrics and gynecology and director of the new PhD program.
Program leaders note that Stanford is among a small number of U.S. universities that have the necessary ingredients to create a doctoral program teaching the full range of stem cell science. They add that although a few other schools have recently established PhD programs involving stem cell biology, Stanford is the first to create a free-standing doctoral program dedicated solely to stem cell biology and regenerative medicine.
A notice for 8 million euros in funding for stem cell projects, a line of research that promises important results for ocular diseases, Parkinson’s, heart diseases, and the fight against tumors was announced by deputy health minister Ferruccio Fazio, who while speaking to the AGI press agency underlined “the importance of regenerative medicine, one of the great hopes for the future, as well as biotechnologies for new treatments altering molecular systems”.
The notification will expire on July 20 and is intended for universities, the National Research Council (CNR), and other private and public research groups. Three independent judges, one of whom will be from abroad, will evaluate the projects that are presented. The research topics eligible for funding include innovative strategies for experimental models (cellular and animal), risk/benefit analysis for pharmacological and non-pharmacological treatments and epidemiology research.
Incoming search terms:regrowing teeth with dental stem cells, Future possiblities of stem cell research, stem cells reaserch for men with azzospermia, the future of stem cell research.
“The tracheal team at Great Ormond Street Hospital is delighted that Ciaran is going home after his tracheal transplant. He is a wonderful boy who has become a great friend to us all, and he and his infinitely patient family have charmed us all. Ciaran has become our local iPad expert, and we will miss his advice. His recovery has been complicated, as one might expect for a new procedure, and we have kept him under close surveillance, hence the length of time he has been here. It is wonderful to see him active, smiling and breathing normally. We are very proud of him!
“Ciaran will continue to need regular follow up by us. This is so we can both make sure he is ok, and also learn what to expect for the next patient who needs this innovative therapy. The treatment offers hope to many whose major airways were previously considered untreatable or irreplaceable. We will continue to work with our colleagues in regenerative medicine throughout the world to ensure we can continue to improve both the science and treatment options.”
A new research has suggested that cardiac stem cells - even in elderly and sick patients – could generate new heart muscle and vessel tissue and be used to treat heart failure.
Scientists surgically removed tissue from the muscular wall of the heart’s chambers in 21 patients.
They then isolated and multiplied the cardiac stem cells (CSCs) found there.
Most of the patients had ischemic cardiomyopathy (enlarged and weakened muscle due to coronary artery disease). Eleven also had diabetes. The average age of patients was about 65.
“Regardless of the gender or age of the patient, or of diabetes, we were able to isolate in all of them a pool of functional cardiac stem cells that we can potentially use to rescue the decompensated human heart,” said Domenico D’Amario, author of the study and a postdoctoral fellow at the Center for Regenerative Medicine at Harvard, Boston, Mass.
The study has been presented at the American Heart Association‘s Scientific Sessions 2010. (ANI)
Incoming search terms:american heart association embryonic, Heart stem cell research, How might stem cells be used to treat disease?, stem cell boston globe transplant, stem cell research for blindness on animals, stem cell russia to increase height, stem cell technologies in boston, stem man.
Official opening of Scottish Centre for Regenerative Medicine and bio-incubator facility, Nine, marks milestone in the growth of Edinburgh BioQuarter.
Research into conditions such as multiple sclerosis and heart and liver disease will benefit from multi-million stem cell research and life sciences facilities due to be opened today (Monday, 28th May) by HRH, the Princess Royal.
The Princess Royal unveiled plaques this afternoon at the £54 million Scottish Centre for Regenerative Medicine (SCRM) and £24 million bio-incubator facility, Nine, in Edinburgh.
The University of Edinburgh’s Scottish Centre for Regenerative Medicine will carry out cutting-edge stem cell research to help find therapies for patients with conditions such as multiple sclerosis, Parkinson’s disease, motor neurone disease, and heart and liver diseases.
The centre is the first large-scale, purpose-built facility of its kind and provides accommodation for up to 250 stem cell scientists. The centre, funded by the University of Edinburgh, Scottish Enterprise, the Medical Research Council (MRC) and the British Heart Foundation through its Mending Broken Hearts Appeal, is being opened by the Princess Royal in her role as Chancellor of the University. It includes the most up-to-date facilities in the UK, which meet the highest guidelines, to manufacture stem cell lines that could be used for patient therapies.
Incoming search terms:edinbrugh nhs regernerative medicine, edinburgh university blood making, stem cell therapy on NHS in Scotland.